Skip to content
healthcare.dev

Ticagrelor

NDC 55488-0544, Ticagrelor, tablet, from Changzhou Pharmaceutical Factory.

Product NDC
55488-0544
Status
Listed
Labeler
Changzhou Pharmaceutical Factory
Dosage form
TABLET
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA216187
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/55488-0544 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • TICAGRELOR60 mg/1

Pharmacologic classes

Cytochrome P450 3A4 Inhibitors [MoA]; Decreased Platelet Aggregation [PE]; P-Glycoprotein Inhibitors [MoA]; P2Y12 Platelet Inhibitor [EPC]; P2Y12 Receptor Antagonists [MoA]

Package NDCNDC-11Package
55488-0544-15548805440160 TABLET in 1 BOTTLE (55488-0544-1)
55488-0544-255488054402500 TABLET in 1 BOTTLE (55488-0544-2)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/751410c1-452b-400b-a640-d31623a6fda3

Use it

Look up 55488-0544 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/55488-0544 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 55488-0544. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.